Rocket Pharmaceuticals
RCKT
RCKT
67 hedge funds and large institutions have $20.7M invested in Rocket Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less funds holding
Funds holding: 82 → 67 (-15)
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
81% less capital invested
Capital invested by funds: $109M → $20.7M (-$87.9M)
Holders
67
Holding in Top 10
1
Calls
$1.02M
Puts
$106K
Top Buyers
| 1 | +$1.97M | |
| 2 | +$1.45M | |
| 3 | +$879K | |
| 4 |
FO
FT Options
Chicago,
Illinois
|
+$593K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$581K |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$11.3M | |
| 3 | -$9.15M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$8.05M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.77M |